Profiel
Mary A. Tagliaferri was the founder of Bionovo, Inc., founded in 2002, where the titles held included President, Secretary, Treasurer & Director from 2011 to 2012.
Current jobs include Director at Iambic Therapeutics, Inc. starting in 2024 and Chief Medical Officer at Nektar Therapeutics starting in 2025.
Former jobs include Director at Atossa Therapeutics, Inc., Independent Director at Rayzebio, Inc. from 2021 to 2024, Independent Director at Enzo Biochem, Inc. from 2023 to 2024, Independent Director at Y-mAbs Therapeutics, Inc. from 2024 to 2025, Secretary, Treasurer & Chief Regulatory Officer at Lighten Up Enterprises International, Inc., and Chief Medical Officer at Kanglaite USA, Inc. from 2012 to 2014.
Education includes an undergraduate degree from Cornell University in 1988, a graduate degree from American College of Traditional Chinese Medicine in 1995, and a doctorate from The University of California, San Francisco in 2002.
Actieve functies van Mary Tagliaferri
| Bedrijven | Functie | Begin |
|---|---|---|
| NEKTAR THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 01-09-2025 |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Directeur/Bestuurslid | 19-09-2024 |
Eerdere bekende functies van Mary Tagliaferri
| Bedrijven | Functie | Einde |
|---|---|---|
| YMAS THER | Directeur/Bestuurslid | 11-07-2025 |
| ENZO BIOCHEM, INC. | Voorzitter | 25-10-2023 |
| RAYZEBIO, INC. | Directeur/Bestuurslid | 26-02-2024 |
Kanglaite USA, Inc.
Kanglaite USA, Inc. Pharmaceuticals: MajorHealth Technology Kanglaite USA, Inc. is a private company based in Redwood City, CA. | Hoofd Techniek/Wetenschap/O&O | 01-06-2014 |
| BIONOVO INC. | Oprichter | 01-06-2012 |
Opleiding van Mary Tagliaferri
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Enzo Biochem, Inc.
Enzo Biochem, Inc. BiotechnologyHealth Technology Provides enabling life science technologies for research, drug discovery, drug development and diagnostic solutions | Health Technology |
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Lighten Up Enterprises International, Inc.
Lighten Up Enterprises International, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Bionovo, Inc.
Bionovo, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals & drugs | Health Technology |
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American College of Traditional Chinese Medicine
American College of Traditional Chinese Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Kanglaite USA, Inc.
Kanglaite USA, Inc. Pharmaceuticals: MajorHealth Technology Kanglaite USA, Inc. is a private company based in Redwood City, CA. | Health Technology |
Rayzebio, Inc.
Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
















